PPD, Inc., a global CRO, has been awarded Defense Health Agency funds to support a five-year Research Project Award (RPA) to develop and execute an adaptive platform clinical research trial of drug interventions to treat post-traumatic stress disorder (PTSD). PPD will work with U.S. Medical Research Development Command U.S. Army Medical Materiel Development Activity’s Warfighter Brain Health Project Management Office to test the effectiveness and safety of at least two pharmacotherapeutic drug c...